Covid-19
Huma’s Medopad platform is a Remote Patient Monitoring (RPM) and Telemedicine solution. It can help to remotely manage patients diagnosed with COVID-19 by tracking symptoms, vital signs, and deterioration, via a virtual ward. It can also automatically flag high-risk patients. A flexible, fast-to-deploy solution, it enables health services to intervene early, optimise clinical resources, and better manage system capacity.
Live projects in the UK with the NHS (facilitated
by NHSX) and Germany
1 million pulse oximeters ordered in support
of projects
Our solution can double capacity to monitor patients remotely
View article
94% patient adherence for our COVID-19 solution1.
Patient age ranges from 18-80 years old
Functionality
It comprises a ‘Medopad’ app for patients paired with a web-based portal for healthcare professionals. We also ship companion medical devices, like digital thermometers and pulse-oximeters, if required.
The app allows patients to remain at home under the remote supervision of their care team. This not only avoids unnecessary travel and exposure, but also helps healthcare systems manage capacity.
Care teams are able to configure thresholds for alerts. They can use the flagging system to identify COVID-19 patients' health deterioration or improvement, and adjust their care plan accordingly.
HOW IT WORKS
Our app safely manages confirmed and suspected COVID-19 patients who are self-isolating using remote monitoring. Patients are invited to download the Medopad app (available on Android and iOS) by their healthcare team to closely track the progress of their COVID-19 infection and to intervene timeously to avoid sudden deterioration.
Monitor COVID-19 symptoms and their severity with a trackable record and automatic flagging systems that detect deterioration. While COVID-19 specific questionnaires capture important information such as background, pre-existing conditions, contact, and travel history.
Patients can use the phone camera to capture their heart rate via validated PPG (photoplethysmography) technology. Or they can manually input the same data using the pulse oximeter device. There’s also the ability to integrate wearables for passive heart rate data collection.
Where necessary, a telemedicine feature allows clinicians to speak to patients quickly and safely.
The app can integrate with third-party body temperature devices. Patients can also manually input their temperature readings to capture one of the key symptoms of COVID-19.
Another vital parameter for early detection, the
app captures oxygen saturation using the pulse oximeter, whether integrated or as a standalone device.
An up-to-date section provides information on the disease and its symptoms, and gives advice on how to prioritise physical and mental wellbeing during this time.
Monitor COVID-19 symptoms and their severity with a trackable record and automatic flagging systems that detect deterioration. While COVID-19 specific questionnaires capture important information such as background, pre-existing conditions, contact, and travel history.
The app can integrate with third-party body temperature devices. Patients can also manually input their temperature readings to capture one of the key symptoms of COVID-19.
Patients can use the phone camera to capture their heart rate via validated PPG (photoplethysmography) technology. Or they can manually input the same data using the pulse oximeter device. There’s also the ability to integrate wearables for passive heart rate data collection.
Another vital parameter for early detection, the app captures oxygen saturation using the pulse oximeter, whether integrated or as a standalone device.
Where necessary, a telemedicine feature allows clinicians to speak to patients quickly and safely.
An up-to-date section provides information on the disease and its symptoms, and gives advice on how to prioritise physical and mental wellbeing during this time.
Pathways
Patient is diagnosed with COVID-19.
Care team prescribes the Medopad app to patient.
Patient with confirmed COVID-19 receives a unique code for the app, and installs the app on their phone. The patient also receives a pulse oximeter device.
The healthcare team provides a unique code to the patient, and instructs them to download the Medopad app.
Patient is presented with specific COVID-19 modules and instructions to monitor vital signs and symptoms.
All patient data is sent in realtime and can be interrogated in detail. Microsite available for HCP and patient training.
Patient continues to report symptoms and vitals signs during each day. Further educational content is available within the app.
Medopad system automatically triages patients based on their vital parameters, and indicates when patient is deteriorating.
Patient is reassured, engaged in their own health and feels safe at home while care is delivered remotely.
The healthcare team can initiate remote consultations with at-risk patients directly from the portal to follow-up on their progress and take appropriate action.
Patient has resumed normal life.
The healthcare team will have accumulated a large body of patient level real-world data for analysis and research, improving understanding of disease processes and patient pathways.
For providers
Key Benefits
You can monitor the progression of COVID-19 infection more frequently, without increasing physical demand on the healthcare system, so that patients are sent to hospital at the right time.
Remote monitoring ensures you can systematically protect COVID-19 patients from sudden life-threatening deterioration.
Use RPM and telemedicine to remotely manage both COVID-19 and high-risk patients (e.g. those who are immunocompromised). Feel confident discharging early, knowing they will receive appropriate monitoring.
Minimise the risk of infection by using the telemedicine functionality to communicate with patients in their own homes.
Any data generated will improve our understanding of the COVID-19 disease process, and aid development of treatments and prevention measures.
CASE STUDY
Our experience in COVID-19
Huma’s RPM for population health management allows patients to remain at home under the supervision of their care team. This reduces unnecessary travel and exposure to others, and eases the burden on healthcare providers who are at capacity.
Care teams are able to configure thresholds for alerts and use the flagging system to identify COVID-19 patients’ health deterioration or improvement, adjusting care plans accordingly.
During 94% of patient days, patients reported oxygen saturation and heart rate data. Data collected between 20 April - 18 August 2020 (n=274)